Now updated to keep professionals current with the latest research and trends in the field, this edition covers both basic science and clinical practice, and draws on the talents of 53 new contributors to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy.
For nearly 30 years, the Manual of Clinical Psychopharmacology has been the preeminent volume on psychotropic medications and the go-to source for psychiatrists prescribing for their patients and students in psychiatry and pharmacology. This new, eighth edition has been thoroughly updated in recognition of the relentless developments in the field, including the release of new U.S. Food and Drug Administration–-approved drugs, newly approved uses for existing drugs, and newly identified interactions, dosing guidelines, and documented side effects. As with previous iterations, this edition is logically structured and highly readable. However, the ever-expanding number of available agents and indications mandated the condensing of some sections and the elimination of others, to keep the book from becoming too large to be user-friendly. The resulting volume is DSM-5 compatible, easy-to-use, and practical, with summary tables for quick reference. The pace and complexity of research in this critical discipline make it essential that clinicians stay abreast of both new medications and promising treatment protocols. The Manual of Clinical Psychopharmacology delivers authoritative information in a friendly, collegial style, maintaining the level of excellence readers have come to expect.
Schatzberg's Manual of Clinical Psychopharmacology is a meticulously researched, yet down-to-earth guide for practitioners prescribing psychotropic medications to individuals with psychiatric disorders or symptoms mandating treatment. The ninth edition offers up-to-date information on current drugs, interactions, side effects, and dosing guidelines, and retains the strengths and features that have made it a standard text for trainees and practicing clinicians. The authors also include a new chapter on important developments in laboratory-guided pharmacotherapy, including pharmacogenomic testing, neurocognitive testing, quantitative EEG, and neuroimaging. Although the book's primary purpose is to provide the reader-practitioner with basic and practical information regarding the many classes of psychiatric medications, the authors stress that understanding how to select and prescribe psychotropic medications does not obviate the basic need to comprehensively evaluate and understand psychiatric patients. Accordingly, the book draws on the authors' clinical experience, as well as on the scientific literature, resulting in an accessible, yet rigorous text. Features that have helped cement this book's reputation include: Coverage is not limited to long-standing and newly approved medications, but also includes agents that are likely to receive approval from the FDA in the near future, ensuring that the reader stays up-to-date. References are provided for key statements, and each chapter is then followed by a list of selected relevant articles and books for readers who want to go beyond the material presented, making for a leaner, more reader-friendly guide. Dozens of summary tables with key information on classes of psychotropics function as quick-reference guides, promoting learning and serving as convenient resources for overloaded clinicians. The appendix offers two kinds of suggested readings. The first, for clinicians, is invaluable to trainees, while the second, for patients and families, helps point clinicians to books aimed at a lay audience to supplement information provided to patients. Staying abreast of both new medications and promising treatment protocols is essential in this rapidly evolving field. Schatzberg's Manual of Clinical Psychopharmacology delivers authoritative information in a friendly, collegial style, ensuring that both students and practicing clinicians are equipped to provide a superior standard of care.
For nearly 30 years, the Manual of Clinical Psychopharmacology has been the preeminent volume on psychotropic medications and the go-to source for psychiatrists prescribing for their patients and students in psychiatry and pharmacology. This new, eighth edition has been thoroughly updated in recognition of the relentless developments in the field, including the release of new U.S. Food and Drug Administration–-approved drugs, newly approved uses for existing drugs, and newly identified interactions, dosing guidelines, and documented side effects. As with previous iterations, this edition is logically structured and highly readable. However, the ever-expanding number of available agents and indications mandated the condensing of some sections and the elimination of others, to keep the book from becoming too large to be user-friendly. The resulting volume is DSM-5 compatible, easy-to-use, and practical, with summary tables for quick reference. The pace and complexity of research in this critical discipline make it essential that clinicians stay abreast of both new medications and promising treatment protocols. The Manual of Clinical Psychopharmacology delivers authoritative information in a friendly, collegial style, maintaining the level of excellence readers have come to expect.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.